Public research preview

Gilbert Cisneros, Representative disclosure: 17 Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)

Disclosed a sell transaction in 17 Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Attention à ne pas courir après
49/100
Qualité du signal
34/100
Qualité des données
93%
Qualité élevée

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
4 Sept 2026, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
36 days

Chronologie

Date de transaction

30 Jul 2026

Déclaration publique

4 Sept 2026

Maintenant

Suivi aujourd’hui

Délai de déclaration: 36 jours

Mouvement du cours

Couverture partielle

Fournisseur
Yahoo Finance daily close
Récupéré
7 sept. 2026

Missing Yahoo Finance daily close for transaction date 2026-07-30, disclosure date 2026-09-04.

Parcours du cours

CRNX du contexte avant transaction jusqu’à la dernière clôture.

Dernier

2 sept. 2026 · 84,95 USD · Pas encore public

Décision du système

N'achèterait pasLes filtres de la stratégie rejettent ce signal. Filtres échoués: Buy disclosure · Filed within 30 days · Pre-disclosure move <= 35%.

Pas encore public84,884,984,9USDDate20 août24 août2 sept.Official disclosure4 sept.Dernier
  • Pas encore public
  • N'achèterait pas
Cours de secours à la transaction
Cours de secours à la déclaration
Dernier cours de secours
Mouvement avant déclaration
Mouvement après déclaration
Mouvement ajusté du marché
1w since disclosure
1m since disclosure
3m since disclosure
Hausse maximale avant déclaration
+0,2 %
Repli depuis le pic
0,0 %

Why Copy Window is Be careful chasing

Supporting factors

  • Parsed sell disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $15,001 - $50,000.
  • Post-disclosure move is currently treated as 0% because market-price coverage is unavailable.

Cautions

  • Missing Yahoo Finance daily close for transaction date 2026-07-30, disclosure date 2026-09-04.
  • Copy Window is using a transaction-price fallback until coverage improves.
  • Price coverage is partial; accepted for official-source intake before market data enrichment.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 4 Sept 2026, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidesell
value15001
sourcehouse_stock_act
tickerCRNX
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20035190.pdf
personNameGilbert Cisneros
amountRange$15,001 - $50,000
companyNameCrinetics Pharmaceuticals, Inc. - Common Stock (CRNX)
publishedAt2026-09-04T00:00:00.000Z
rawDocumentIdraw-us-house-20035190-16
disclosureDate2026-09-04
transactionDate2026-07-30
transactionTypeS